22nd Century Group Inc(XXII) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows to alter the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. The company offers SPECTRUM research cigarettes for use in independent clinical studies; and very low nicotine content (VLNC) tobacco cigarettes under the Moonlight and Moonlight Menthol brands. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical, therapeutic, and agricultural uses, as well as for other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Current Price

$4.37

RSI

49.064

Beta:

1.73359

March 11, 2021
786K
-3.1M

-0.103 %
5.263 %
-3.333 %
43.724 %

$28,039,000
$25,832,530
$26,426,347
$16,600,244
$12,279,979
$8,521,998
8.541 %
-2.299 %
59.193 %
35.181 %
44.097 %

$-19,673,000
$-32,110,544
$-9,426,911
$-13,029,117
$-11,581,430
$-11,031,931
63.221 %
-70.642 %
38.212 %
-11.111 %
-4.745 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.